Integrated Hemophilia Patient Care via a National Network of Care Centers in the United States: A Model for Rare Coagulation Disorders

References

• Iorio A, Stonebraker JS, Chambost H, et al. Establishing the prevalence and prevalence at birth of hemophilia in males: a meta-analytic approach using national registries. Ann Intern Med. 2019;171(8):540–546. doi:10.7326/M19-1208
   PubMed Web of Science ®Google Scholar
• O’Hara J, Walsh S, Camp C, et al. The impact of severe haemophilia and the presence of target joints on health-related quality-of-life. Health Qual Life Outcomes. 2018;16(1):84. doi:10.1186/s12955-018-0908-9
   PubMed Web of Science ®Google Scholar
• Pipe SW. New therapies for hemophilia. Hematology Am Soc Hematol Educ Program. 2016;2016(1):650–656. doi:10.1182/asheducation-2016.1.650
   PubMed Web of Science ®Google Scholar
• Nacca CR, Harris AP, Tuttle JR. Hemophilic arthropathy. Orthopedics. 2017;40(6):e940–e946. doi:10.3928/01477447-20170619-05
   PubMed Web of Science ®Google Scholar
• McLintock C. Women with bleeding disorders: clinical and psychological issues. Haemophilia. 2018;24(Suppl 6):22–28. doi:10.1111/hae.13501
   Web of Science ®Google Scholar
• National Hemophilia Foundation. Comprehensive hemophilia management: a payer’s guide to the hemophilia comprehensive care model. Available from: https://www.managedcarehemo.com/wp-content/uploads/2017/09/Payeru2019s-Guide-to-the-Hemophilia-Comprehensive-Care-Model.pdf. Accessed February 9, 2021.
   Google Scholar
• Aledort LM. The evolution of comprehensive haemophilia care in the United States: perspectives from the frontline. Haemophilia. 2016;22(5):676–683. doi:10.1111/hae.12970
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Community counts: HTC population profile. Available from: https://www.cdc.gov/ncbddd/hemophilia/communitycounts/data-reports/2021-03/table-1-patient-characteristics-by-calendar.html. Accessed July 28, 2021.
   Google Scholar
• Baker JR, Riske B, Drake JH, et al. US Hemophilia Treatment Center population trends 1990–2010: patient diagnoses, demographics, health services utilization. Haemophilia. 2013;19(1):21–26. doi:10.1111/j.1365-2516.2012.02915.x
   PubMed Web of Science ®Google Scholar
• Dalton DR. Hemophilia in the managed care setting. Am J Manag Care. 2015;21(6 Suppl):S123–S130.
   PubMed Web of Science ®Google Scholar
• Comprehensive Care Sustainability Collaborative. HTC success in a value-based health care environment: findings from the Comprehensive Care Sustainability Collaborative (CCSC). Available from: https://www.ccschemo.com/webcast20/. Accessed September 17, 2021.
   Google Scholar
• Croteau SE, Cheng D, Cohen AJ, et al. Regional variation and cost implications of prescribed extended half-life factor concentrates among U.S. haemophilia treatment centres for patients with moderate and severe haemophilia. Haemophilia. 2019;25(4):668–675.
   PubMed Web of Science ®Google Scholar
• Goodman C, Rangarao S, Rubin RJ; The Lewin Group. National hemophilia foundation: strategic summit report. Available from: https://www.hemophilia.org/sites/default/files/document/files/HemophiliaSummitFinalReportOct2012.pdf. Accessed February 4, 2021.
   Google Scholar
• Di Minno G, Tremoli E. Tailoring of medical treatment: hemostasis and thrombosis towards precision medicine. Haematologica. 2017;102(3):411–418. doi:10.3324/haematol.2016.156000
   Web of Science ®Google Scholar
• Mazepa MA, Monahan PE, Baker JR, et al. Men with severe hemophilia in the United States: birth cohort analysis of a large national database. Blood. 2016;127(24):3073–3081. doi:10.1182/blood-2015-10-675140
   PubMed Web of Science ®Google Scholar
• White GC. Hemophilia: an amazing 35-year journey from the depths of HIV to the threshold of cure. Trans Am Clin Climatol Assoc. 2010;121:61–73.
   Google Scholar
• Mejia-Carvajal C, Czapek EE, Valentino LA. Life expectancy in hemophilia outcome. J Thromb Haemost. 2006;4(3):507–509. doi:10.1111/j.1538-7836.2006.01776.x
   PubMed Web of Science ®Google Scholar
• National Hemophilia Foundation. History from 2AD to the present. Available from: https://www.hemophilia.org/bleeding-disorders-a-z/overview/history. Accessed July 29, 2021.
   Google Scholar
• Pai M, Key NS, Skinner M, et al. NHF-McMaster guideline on care models for haemophilia management. Haemophilia. 2016;22(Suppl):36.
   Google Scholar
• Srivastava A, Santagostino E, Dougall A, et al. WFH guidelines for the management of hemophilia, 3rd edition. Haemophilia. 2020;26(Suppl 6):1–158. doi:10.1111/hae.14046
   PubMed Web of Science ®Google Scholar
• Reding MT, Kenney J. Hemophilia care coordination and current treatment options: the latest insights for managed care and specialty pharmacy. Available from: https://www.managedcarehemo.com/cmece/. Accessed February 4, 2021.
   Google Scholar
• National Hemophilia Foundation. Comprehensive medical care: HTCs. Available from: https://www.hemophilia.org/healthcare-professionals/guidelines-on-care/comprehensive-medical-care. Accessed October 24, 2020.
   Google Scholar
• Mitchell P, Wynia M, Golden R, et al. Core principles & values of effective team-based health care. Presented at: National Academy of Medicine (Discussion Paper); October 2, 2012; Washington, DC.
   Google Scholar
• Weill Cornell Medicine. Comprehensive hemophilia treatment center: research. Available from: https://hemophilia.weill.cornell.edu/research. Accessed April 17, 2021.
   Google Scholar
• Center for Disease Control. Hemphilia treatment centers. Available from: https://www.cdc.gov/ncbddd/hemophilia/documents/a-simmons_htc-brochure-508c.pdf. Accessed July 30, 2021.
   Google Scholar
• Medical and Scientific Advisory Council. MASAC documents. Available from: https://www.hemophilia.org/healthcare-professionals/guidelines-on-care/masac-documents. Accessed July 30, 2021.
   Google Scholar
• University of Vermont Larner Colllege of Medicine. The vermont regional hemophilia treatment center: coagulation lab. Available from: https://www.med.uvm.edu/medicine/hemonc/patient_care_-vermont_regional_hemophilia_treatment_center. Accessed April 17, 2021.
   Google Scholar
• National Hemophilia Foundation. MASAC Document 262 - MASAC resolution on off-site hemostasis testing. Available from: https://www.hemophilia.org/healthcare-professionals/guidelines-on-care/masac-documents/masac-document-262-masac-resolution-on-off-site-hemostasis-testing. Accessed May 5, 2021.
   Google Scholar
• Skinner MW, Soucie JM, McLaughlin K. The National Haemophilia Program standards, evaluation and oversight systems in the United States of America. Blood Transfus. 2014;12(Suppl 3):e542–e548.
   PubMed Web of Science ®Google Scholar
• Malouin RA, McKernan L, Forsberg A, et al. Impact of the 340B pharmacy program on services and supports for persons served by hemophilia treatment centers in the United States. Matern Child Health J. 2018;22(9):1240–1246. doi:10.1007/s10995-018-2545-7
   PubMed Web of Science ®Google Scholar
• New York Blood Center. About New York Blood Center pharmacy: pharmacy services. Available from: https://www.nybloodcenter.org/products-and-services/medical-services/hemophilia-services/pharmacy-services/. Accessed April 17, 2021.
   Google Scholar
• National Hemophilia Foundation. MASAC Document 188 - recommendations regarding standards of service for pharmacy providers of clotting factor concentrates for home use to patients with bleeding disorders. Available from: https://www.hemophilia.org/healthcare-professionals/guidelines-on-care/masac-documents/masac-document-188-recommendations-regarding-standards-of-service-for-pharmacy-providers-of-clotting-factor-concentrates-for-home-use-to-patients-with-bleeding-disorders. Accessed November 21, 2020.
   Google Scholar
• Centers for Disease Control and Prevention. Hemophilia treatment center directory. Available from: https://dbdgateway.cdc.gov/HTCDirSearch.aspx. Accessed July 30, 2021.
   Google Scholar
• Baker JR, Crudder SO, Riske B, Bias V, Forsberg A. A model for a regional system of care to promote the health and well-being of people with rare chronic genetic disorders. Am J Public Health. 2005;95(11):1910–1916. doi:10.2105/AJPH.2004.051318
   PubMed Web of Science ®Google Scholar
• Lin TF, Carhill P, Huang JN, Baker JR. Capacity building for rare bleeding disorders in the remote commonwealth of the Northern Mariana Islands. Am J Public Health. 2016;106(4):658–661. doi:10.2105/AJPH.2016.303093
   Web of Science ®Google Scholar
• Recht M, Konkle BA, Jackson S, et al. Recognizing the need for personalization of haemophilia patient-reported outcomes in the prophylaxis era. Haemophilia. 2016;22(6):825–832. doi:10.1111/hae.13066
   Web of Science ®Google Scholar
• Roberts JC, Lattimore S, Recht M, et al. Goal Attainment Scaling for haemophilia (GAS-Hem): testing the feasibility of a new patient-centric outcome measure in people with haemophilia. Haemophilia. 2018;24(4):e199–e206. doi:10.1111/hae.13454
   PubMed Web of Science ®Google Scholar
• Escobar MA, Brewer A, Caviglia H, et al. Recommendations on multidisciplinary management of elective surgery in people with haemophilia. Haemophilia. 2018;24(5):693–702. doi:10.1111/hae.13549
   PubMed Web of Science ®Google Scholar
• Foundation for Women & Girls With Blood Disorders. Blood disorders resources. Available from: https://www.fwgbd.org/resources/blood-disorders. Accessed August 3, 2021.
   Google Scholar
• Chaudhury A, Sidonio R Jr., Jain N, et al. Women and girls with haemophilia and bleeding tendencies: outcomes related to menstruation, pregnancy, surgery and other bleeding episodes from a retrospective chart review. Haemophilia. 2021;27(2):293–304. doi:10.1111/hae.14232
   PubMed Web of Science ®Google Scholar
• American College of Obestricians and Gynecologists. Management of acute abnormal uterine bleeding in nonpregnant reproductive-aged women. Obstet Gynecol. 2013;121:891–896. doi:10.1097/01.AOG.0000428646.67925.9a
   Google Scholar
• Kirtava A, Crudder S, Dilley A, Lally C, Evatt B. Trends in clinical management of women with von Willebrand disease: a survey of 75 women enrolled in haemophilia treatment centres in the United States. Haemophilia. 2004;10(2):158–161. doi:10.1046/j.1351-8216.2003.00832.x
   PubMed Web of Science ®Google Scholar
• Angelini D, Konkle BA, Sood SL. Aging among persons with hemophilia: contemporary concerns. Semin Hematol. 2016;53(1):35–39. doi:10.1053/j.seminhematol.2015.10.004
   PubMed Web of Science ®Google Scholar
• Mannucci PM. Aging with hemophilia: the challenge of appropriate drug prescription. Mediterr J Hematol Infect Dis. 2019;11(1):e2019056. doi:10.4084/mjhid.2019.056
   PubMed Web of Science ®Google Scholar
• Schieve L, Byams V, Dupervil B, et al. Evaluation of CDC’s Hemophilia Surveillance Program — universal data collection (1998–2011) and community counts (2011–2019), United States. MMWR Surveill Summ. 2020;69(5):1–18. doi:10.15585/mmwr.ss6905a1
   Web of Science ®Google Scholar
• Byams VR, Kouides PA, Kulkarni R, et al. Surveillance of female patients with inherited bleeding disorders in United States haemophilia treatment centres. Haemophilia. 2011;17(Suppl 1):6–13. doi:10.1111/j.1365-2516.2011.02558.x
   Web of Science ®Google Scholar
• Kulkarni R, Presley RJ, Lusher JM, et al. Complications of haemophilia in babies (first two years of life): a report from the Centers for Disease Control and Prevention Universal Data Collection System. Haemophilia. 2017;23(2):207–214. doi:10.1111/hae.13081
   PubMed Web of Science ®Google Scholar
• Pepper L. National databases improve bleeding disorders care. Available from: https://hemaware.org/bleeding-disorders-z/national-databases-improve-bleeding-disorders-care. Accessed October 25, 2020.
   Google Scholar
• American Thrombosis and Hemostasis Network. My life, our future research repository. Available from: https://athn.org/what-we-do/national-projects/mlof-research-repository.html. Accessed August 3, 2021.
   Google Scholar
• Soucie JM, Nuss R, Evatt B, et al. Mortality among males with hemophilia: relations with source of medical care. The Hemophilia Surveillance System Project Investigators. Blood. 2000;96(2):437–442.
   Web of Science ®Google Scholar
• Soucie JM, Symons J 4th, Evatt B, et al. Home-based factor infusion therapy and hospitalization for bleeding complications among males with haemophilia. Haemophilia. 2001;7(2):198–206. doi:10.1046/j.1365-2516.2001.00484.x
   Web of Science ®Google Scholar
• Okolo AI, Soucie JM, Grosse SD, et al. Population-based surveillance of haemophilia and patient outcomes in Indiana using multiple data sources. Haemophilia. 2019;25(3):456–462. doi:10.1111/hae.13734
   Web of Science ®Google Scholar
• American Thrombosis and Hemostasis Network. American thrombosis and hemostasis network: overview. Available from: https://athn.org/who-we-are/about/overview.html. Accessed November 21, 2020.
   Google Scholar
• National HTC Patient Satisfaction Survey. Third patient satisfaction survey of the U.S. Hemophilia Treatment Centers. Available from: http://www.htcsurvey.com/examplesurvey. Accessed April 17, 2021.
   Google Scholar
• Riske B, Shearer R, Baker JR. Patient satisfaction with US hemophilia treatment center care, teams and services: the first national survey. Haemophilia. 2020;26(6):991–998. doi:10.1111/hae.14176
   PubMed Web of Science ®Google Scholar
• Lattimore S, Shearer R, Ashton M, Riske B, Baker J. Patient satisfaction with US hemophilia treatment centers: national trends 2014 and 2017. Presented at: Hempstasis and Thrombosis Research Society; May 2019; New Orleans, LA.
   Google Scholar
• Butler RB, Cheadle A, Aschman DJ, et al. National needs assessment of patients treated at the United States federally-funded hemophilia treatment centers. Haemophilia. 2016;22(1):e11–e17. doi:10.1111/hae.12810
   PubMed Web of Science ®Google Scholar
• Shapiro A, Pipe SW, Geraghty S, et al. Hemophilia and managed care: partnering to achieve cost-effective care. Pharm Times. 2011;3(5):248–255.
   Google Scholar
• Tarantino MD, Pindolia VK. Hemophilia management via data collection and reporting: initial findings from the Comprehensive Care Sustainability Collaborative. J Manag Care Spec Pharm. 2017;23(1):51–56.
   PubMed Web of Science ®Google Scholar
• United States Congress. The Public Health Service Act establishing the hemophilia diagnostic and treatment center program. In: Congress US, editor. Number 1131 of Public Law 9463. Washington, D.C.: Government Printing Office; 1975.
   Google Scholar
• National Hemophilia Foundation. What we do. Available from: https://www.hemophilia.org/who-we-are/our-story/what-we-do. Accessed August 5, 2021.
   Google Scholar
• Health Resources and Services Administration. Comprehensive hemophilia treatment centers. Available from: https://www.hrsa.gov/opa/eligibility-and-registration/specialty-clinics/hemophilia/index.html. Accessed August 5, 2021.
   Google Scholar
• Qian W, Lam TT, Lam HHW, Li CK, Cheung YT. Telehealth interventions for improving self-management in patients with hemophilia: scoping review of clinical studies. J Med Internet Res. 2019;21(7):e12340. doi:10.2196/12340
   PubMed Web of Science ®Google Scholar
• Valentino LA, Skinner MW, Pipe SW. The role of telemedicine in the delivery of health care in the COVID-19 pandemic. Haemophilia. 2020;26(5):e230–e231. doi:10.1111/hae.14044
   PubMed Web of Science ®Google Scholar
• Boccalandro EA, Dallari G, Mannucci PM. Telemedicine and telerehabilitation: current and forthcoming applications in haemophilia. Blood Transfus. 2019;17(5):385–390.
   PubMed Web of Science ®Google Scholar